JUN 02, 2022 8:30 AM PDT

Round Table discussion - Role of Risk Stratification for Cardio Vascular Disease in the COVID-19 era and its economic benefits

Sponsored by: Abbott
Speakers

Abstract
Date:  June 02, 2022
Time: 8:30am (PDT), 10:30am (CDT), 11:30pm (EDT)
 
Cardiovascular diseases (CVD) are considered a major global health problem. CVD is the leading cause of premature death worldwide, and it imposes a high burden on individuals, households, health systems, and societies. Because modifiable and preventable risk factors have a crucial influence on CVD morbidity and mortality, primary prevention is key to successfully reducing the burden of the disease.
Join this session to learn from a panel of experts in CVD prevention about 1) the recent evidence for using High Sensitive Troponin I (hsTnI) as a novel biomarker of CVD risk in asymptomatic populations; 2) an algorithm to incorporate hsTnI into risk prediction and clinical management as well as an example of the adoption of hsTnI in risk stratification; 3) the health economic implications of screening and risk assessment strategies in general and the current health economic evidence of using hsTnI for cardiovascular risk assessment and; 4) the implementation learnings and best practices shared by Medcan Clinic.
 
Learning Objectives
  • Discuss the recent evidence for using High Sensitive Troponin I (hs TnI) as a novel biomarker of CVD risk in asymptomatic populations 
  • Describe the algorithm to incorporate hs TnI into risk prediction and clinical management
  • Explain the health economic evidence of using hsTnI for cardiovascular risk assessment
  • Discuss the implementation learnings and best practices shared by Medcan Clinic
 
This webinar will be moderated by Dr. Christos Varounis, MD, MSc, MBA - Cardiologist, Medical Director, Medical Affairs, Abbot Core Diagnostics.
 
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds